CIK: 1415537 - Address: C/O Merus N.V., Uppsalalaan 17, Utrecht, P7 3584 CT
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11105-1-19-34-43-18
P%wins100100000033

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/5/24 16:04
1/4/24
KALAKala Bio, Inc.DEHealthDrugPharmaceutical PreparationsIwicki Mark TMADOCEOS.d-316.730-5-2286D
4/17/23 08:26
4/14/23
MRUSMerus N.V.P7HealthDrugPharmaceutical PreparationsIwicki Mark TP7DM.d5357.27074New74D
1/6/23 20:00
1/4/23
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsIwicki Mark TMADOCEOS-628.5400046D
10/28/22 16:15
10/26/22
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsIwicki Mark TMADOCEOS-46.520-1-114D
6/29/22 20:09
6/27/22
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsIwicki Mark TMADOCEOS-30.37000-8-3251D
1/5/22 20:00
1/4/22
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsIwicki Mark TMADOCEOS.d-121.300-10-4259D
10/28/21 20:01
10/26/21
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsIwicki Mark TMADOCEOS-501.800-28-9269D
6/29/21 17:25
6/28/21
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsIwicki Mark TMADOCEOS-445.770-8-2296D
4/5/18 20:07
4/3/18
PULMPulmatrix, Inc.DEHealthDrugPharmaceutical PreparationsIwicki Mark TMADP.d00.000307New307D
2/26/18 16:05
2/26/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsIwicki Mark TCADP30032.00094729D
8/11/15 11:40
8/11/15
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsIwicki Mark TCADP32016.003320New20D05-1-19-34-43

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact